PROK — Prokidney Income Statement
0.000.00%
Last trade - 00:00- $483.07m
- $1.53bn
- $0.89m
Annual income statement for Prokidney, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0.076 | 0.893 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 55.1 | 153 | 152 | 184 | 166 |
| Operating Profit | -55.1 | -153 | -152 | -184 | -165 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -55.1 | -147 | -129 | -164 | -151 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -55.1 | -148 | -135 | -163 | -152 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -55.1 | -108 | -35.5 | -61.2 | -69 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -55.1 | -108 | -35.5 | -61.2 | -69 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.896 | -1.76 | -0.575 | -0.59 | -0.513 |
| Dividends per Share |